News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
486,600 Results
Type
Article (8040)
Company Profile (141)
Press Release (478418)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166962)
Career Advice (303)
Deals (25765)
Drug Delivery (7)
Drug Development (52943)
Employer Resources (14)
FDA (9776)
Job Trends (8576)
News (238515)
Policy (17924)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (494)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (98)
Alliances (33238)
ALS (110)
Alzheimer's disease (985)
Antibody-drug conjugate (ADC) (284)
Approvals (10425)
Artificial intelligence (336)
ASCO (160)
Autoimmune disease (220)
Automation (29)
Bankruptcy (263)
Belgium (1)
Best Places to Work (6966)
BIO (36)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (17)
Biotechnology (89)
Bispecific (1)
Bladder cancer (139)
Brain cancer (31)
Breast cancer (521)
Cancer (3778)
Cardiovascular disease (226)
Career advice (246)
Career pathing (2)
CAR-T (178)
CDC (1)
CDMO (15)
Celiac Disease (1)
Cell therapy (486)
Cervical cancer (35)
Clinical research (48128)
Collaboration (1284)
Commercialization (3)
Compensation (1535)
Complete response letters (34)
COVID-19 (772)
CRISPR (64)
C-suite (805)
Cystic fibrosis (87)
Data (5869)
Denatured (4)
Depression (106)
Dermatology (67)
Diabetes (354)
Diagnostics (4262)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (161)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73838)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88251)
Executive appointments (714)
FDA (12519)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (949)
Gene editing (126)
Generative AI (11)
Gene therapy (333)
GLP-1 (297)
Government (954)
Grass and pollen (2)
Guidances (281)
Healthcare (9385)
Hematology (94)
HIV (55)
Huntington's disease (23)
IgA nephropathy (68)
Immunology and inflammation (106)
Immuno-oncology (61)
Indications (162)
Infectious disease (967)
Inflammatory bowel disease (129)
Inflation Reduction Act (4)
Influenza (87)
Intellectual property (261)
Interviews (41)
IPO (12404)
IRA (2)
Job creations (1969)
Job search strategy (236)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Leadership (1)
Legal (5196)
Licensing (18)
Liver cancer (45)
Longevity (19)
Lung cancer (544)
Lymphoma (257)
Machine learning (29)
Management (3)
Manufacturing (565)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8694)
Medtech (8853)
Mergers & acquisitions (14424)
Metabolic disorders (726)
mRNA (63)
Multiple sclerosis (108)
NASH (4)
Neurodegenerative disease (230)
Neuropsychiatric disorders (40)
Neuroscience (1874)
NextGen: Class of 2026 (3154)
Non-profit (845)
Obesity (231)
Opinion (10)
Ovarian cancer (162)
Pain (177)
Pancreatic cancer (207)
Parkinson's disease (206)
Partnered (12)
Patents (498)
Patient recruitment (532)
Patient selection (2)
Peanut (32)
People (41414)
Peptides (2)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15552)
Phase 2 (21476)
Phase 3 (14508)
Pipeline (7717)
Policy (18)
Postmarket research (1571)
Preclinical (6564)
Press Release (34)
Prostate cancer (194)
Psychedelics (7)
Radiopharmaceuticals (195)
Rare diseases (592)
Real estate (3028)
Recruiting (6)
Regenerative medicine (2)
Regulatory (14999)
Reports (23)
Research institute (588)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (49)
Schizophrenia (102)
Series A (163)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (90)
Sponsored (5)
Startups (2022)
Stomach cancer (3)
Supply chain (51)
Vaccines (335)
Venture capital (17)
Weight loss (75)
Women's health (88)
Date
Last 7 days (287)
Last 30 days (1343)
Last 365 days (19074)
2026 (13668)
2025 (19312)
2024 (23054)
2023 (26588)
2022 (34679)
2021 (37259)
2020 (33521)
2019 (23307)
2018 (17515)
2017 (18782)
2016 (17945)
2015 (24289)
2014 (21690)
2013 (18150)
2012 (20252)
2011 (20467)
2010 (20363)
Location
Africa (227)
Alabama (77)
Alaska (2)
Arizona (310)
Arkansas (10)
Asia (18095)
Australia (2131)
California (12370)
Canada (3241)
China (549)
Colorado (497)
Connecticut (427)
Delaware (214)
Europe (24863)
Florida (1887)
Georgia (393)
Hawaii (3)
Idaho (46)
Illinois (728)
India (51)
Indiana (323)
Iowa (16)
Japan (423)
Kansas (103)
Kentucky (32)
Louisiana (27)
Maine (26)
Maryland (1232)
Massachusetts (8115)
Michigan (314)
Minnesota (573)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (122)
New Hampshire (60)
New Jersey (2693)
New Mexico (12)
New York (2898)
North Carolina (1319)
North Dakota (4)
Northern California (6212)
Ohio (293)
Oklahoma (14)
Oregon (16)
Pennsylvania (2296)
Puerto Rico (21)
Rhode Island (30)
South America (402)
South Carolina (78)
South Dakota (1)
Southern California (5160)
Tennessee (126)
Texas (2004)
United States (40100)
Utah (372)
Vermont (1)
Virginia (159)
Washington D.C. (38)
Washington State (956)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
486,600 Results for "tekni plex inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀
July 29, 2026
·
6 min read
Press Releases
PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀
June 1, 2026
·
5 min read
Press Releases
PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
July 21, 2026
·
8 min read
Press Releases
PolyPid Initiates D-PLEX₁₀₀ NDA Submission to the FDA
March 31, 2026
·
5 min read
Press Releases
PolyPid Receives PDUFA Fee Waiver from FDA for D-PLEX₁₀₀’s New Drug Application
March 17, 2026
·
5 min read
Press Releases
PolyPid to Present New Phase 3 SHIELD II Data Demonstrating D-PLEX₁₀₀ Sustained Local Release at ESCMID Global 2026
April 14, 2026
·
6 min read
Deals
Tekni-Plex Acquires Johnson Plastic Group, Expands Medical Device Footprint
Tekni-Plex Healthcare has acquired precision extrusion manufacturer Johnson Plastic Group (JPG) as part of a strategy to expand the company’s patient care solutions platform.
October 7, 2021
·
2 min read
Press Releases
Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research
January 13, 2026
·
2 min read
Press Releases
PolyPid Announces Positive FDA Pre-NDA Meeting Minutes for D-PLEX₁₀₀ Supporting NDA Submission
December 4, 2025
·
5 min read
Press Releases
PolyPid’s D-PLEX₁₀₀ Wins BioTech Breakthrough Award for “Therapeutics Solution of the Year”
November 7, 2025
·
6 min read
1 of 48,660
Next
